Crossmark

Induction of neutralizing antibodies against tier 2 human immunodeficiency virus 1 in rhesus macaques infected with tier 1B simian/human immunodeficiency virus

Crossref DOI link: https://doi.org/10.1007/s00705-019-04173-5

Published Online: 2019-02-28

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Himeno, Ai

Ishida, Yuki

Mori, Hiromi

Matsuura, Kanako

Kikukawa, Minako

Sakawaki, Hiromi

Miura, Tomoyuki https://orcid.org/0000-0002-1956-2180
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP18fk0410011)

Japan Agency for Medical Research and Development (JP18fk0410002)

Japan Agency for Medical Research and Development (JP18fk0410013)

Japan Society for the Promotion of Science (16H04682)
License Information

Text and Data Mining valid from 2019-02-28

Version of Record valid from 2019-02-28
More Information

Article History

Received: 7 September 2018

Accepted: 17 January 2019

First Online: 28 February 2019

Compliance with ethical standards

:

: The authors have no conflicts of interest to declare.

: All animal studies were performed under anesthesia and adhered to protocols approved by the Committee for Experimental Use of Non-Human Primates of the Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan. Macaques were housed in a biosafety level 3 facility in which all of the procedures were performed.

Document is current

Any future updates will be listed below